David I. Marks
Impact in
- Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
- Hematology 106
- Hematopoietic Stem Cell Transplantation 60
- Chronic Myeloid Leukemia Treatments 42
- Acute Myeloid Leukemia Research 30
-
- Acute Lymphoblastic Leukemia research 84
- Co-authors
- Lucy Yardley (1 shared paper)Hillard M. Lazarus (35 shared papers)Martin S. Tallman (21 shared papers)Mark R. Litzow (24 shared papers)Adele K. Fielding (30 shared papers)Richard E. Champlin (9 shared papers)Jacob M. Rowe (17 shared papers)Andrew McMillan (21 shared papers)
- Journals
- Blood (38 papers)Biology of Blood and Marrow Transplantation (26 papers)British Journal of Haematology (20 papers)Journal of Clinical Oncology (9 papers)Cancer (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David I. Marks
159 papers receiving 10.2k citations
David I. Marks's Hit Papers
Peers
Comparison fields: 5 of 174
- Hematology 6.2k
- Public Health, Environmental and Occupational Health 3.8k
- Transplantation 343
- Genetics 1.4k
- Oncology 2.4k
Countries citing papers authored by David I. Marks
This map shows the geographic impact of David I. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Marks more than expected).
Fields of papers citing papers by David I. Marks
This network shows the impact of papers produced by David I. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Marks. The network helps show where David I. Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside David I. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia Hit paper breakdown → | 2004 | 833 |
| 2 | Research Methods for Clinical and Health Psychology Hit paper breakdown → | 2004 | 684 |
| 3 | Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Hit paper breakdown → | 2006 | 616 |
| 4 | In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) Hit paper breakdown → | 2007 | 579 |
| 5 | 2010 | 419 | |
| 6 | 2010 | 353 | |
| 7 | 2010 | 306 | |
| 8 | 2009 | 278 | |
| 9 | 2015 | 278 | |
| 10 | 2013 | 262 | |
| 11 | 2011 | 256 | |
| 12 | Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. | 2002 | 211 |
| 13 | 2009 | 209 | |
| 14 | 2011 | 182 | |
| 15 | 1993 | 164 | |
| 16 | 2012 | 155 | |
| 17 | 2017 | 155 | |
| 18 | 2003 | 153 | |
| 19 | 2020 | 150 | |
| 20 | 2010 | 145 |
About David I. Marks
David I. Marks is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Immunology and Genetics, having authored 167 papers that have together received 10.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (84 papers), Hematopoietic Stem Cell Transplantation (60 papers), Chronic Myeloid Leukemia Treatments (42 papers), Acute Myeloid Leukemia Research (30 papers), CAR-T cell therapy research (22 papers), Childhood Cancer Survivors' Quality of Life (16 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Hematology (6.2k citations), Public Health, Environmental and Occupational Health (3.8k citations), Transplantation (343 citations), Genetics (1.4k citations) and Oncology (2.4k citations). David I. Marks has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Lucy Yardley, Hillard M. Lazarus, Martin S. Tallman, Mark R. Litzow, Adele K. Fielding, Richard E. Champlin, Jacob M. Rowe, Andrew McMillan, Mary M. Horowitz and Selina M. Luger. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, British Journal of Haematology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.